Geometry.Net - the online learning center
Home  - Health_Conditions - Hepatic Encephalopathy
e99.com Bookstore
  
Images 
Newsgroups
Page 5     81-93 of 93    Back | 1  | 2  | 3  | 4  | 5 
A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z  

         Hepatic Encephalopathy:     more books (47)
  1. Hepatic Encephalopathy: Syndromes and Therapies by Harold O. Conn, 1994-01
  2. Hepatic Encephalopathy by Alan H. Lockwood, 1992-11
  3. Cirrhosis, Hepatic Encephalopathy and Ammonium Toxicity (Advances in Experimental Medicine and Biology)
  4. Hepatic Encephalopathy in Chronic Liver Failure
  5. Hepatic Encephalopathy - A Medical Dictionary, Bibliography, and Annotated Research Guide to Internet References by ICON Health Publications, 2004-10-04
  6. Cirrhosis, Hyperammonemia, and Hepatic Encephalopathy (Advances in Experimental Medicine and Biology)
  7. Advances in Hepatic Encephalopathy and Metabolic Nitrogen Exchange by Livio Capocaccia, Manuela Merli, et all 1994-12-27
  8. Advances in Cirrhosis, Hyperammonemia, and Hepatic Encephalopathy (Advances in Experimental Medicine and Biology)
  9. Hepatic Encephalopathy: Management With Lactulose and Related Carbohydrates by Harold O. Conn, 1988-10
  10. Hepatic Encephalopathy and Nitrogen Metabolism
  11. Hepatic Encephalopathy, Hyperammonemia and Toxicity (Advances in Experimental Medicine and Biology)
  12. Hepatic Encephalopathy: Pathophysiology and Treatment (Experimental Biology and Medicine) by Roger F. Butterworth, Gilles Pomier Layrargues, 1989-10-01
  13. Progress in Hepatic Encephalo & Metabolic Nitrogen by Bengt Jeppsson, Finn Bengtsson, 1991-04-24
  14. Encephalopathy and Nitrogen Metabolism in Liver Failure

81. Karger Publishers
Advances in hepatic encephalopathy and Urea Cycle Diseases. 5th International Vienna).Advances in hepatic encephalopathy and Urea Cycle Diseases. 5th
http://content.karger.com/ProdukteDB/produkte.asp?Aktion=showproducts&ProduktNr=

82. MELD Score,Metabolic Liver Disease,Minimal Hepatic Encephalopathy,Non-alcoholic
MELD score,Metabolic liver disease,Minimal hepatic encephalopathy,Nonalcoholicsteato-hepatitis,Non-cirrhotic portal fibrosis,Overlap syndrome,Portal
http://www.apaslindia2004.com/highlights.asp
Home About APASL APASL Conference India 2004 December 11-15, 2004 New Delhi Welcome Message About Conference Scientific Program Post Graduate Course Core Meeting Parallel Session Workshops Faculty Registration Abstracts Logistic Support ... APASL Conference Updates
Highlights of Conference
  • Postgraduate Course
    Plenary and Young Investigator Paper Sessions
    A . Attractive awards:
    ( i ) Plenary session (separate awards for basic and clinical science)
    ( ii ) Young investigator session
    B . Travel Fellowships
    Okuda Memorial Symposium
    Presidential oration by Past President APASL
    Parallel Sessions (Half / Full day)
  • Surgical Hepatology Hepatic Radiology Liver Pathology Pediatric Hepatology Molecular Hepatology Nutrition in Liver Disease Workshop: Endoscopic and Radiological Procedures in Hepatology Breakfast Sessions, Meet-the-Professor Industry Sponsored Satellite Symposia Awards and Financial Grants
  • Home Scientific Program Scientific Committee Advisors ... Contact Us © APASL - Asian Pacific Association for the Study of the Liver, Room No. 210, Academic Block, G. B. Pant Hospital, New Delhi - 110002, India

    83. Search Health Information
    Back to Search hepatic encephalopathy (Disease). hepatic encephalopathy is brainand nervous system damage that occurs as a complication of liver disorders.
    http://www.iowahealth.org/body.cfm?id=692&action=detail&AEProductID=AdamEncy&AEA

    84. Hepatic Encephalopathy
    hepatic encephalopathy (HE) SX DX RX. hepatic encephalopathy is a complexneuropsychiatric disorder that complicates acute and chronic liver failure.
    http://members.tripod.com/enotes/hepatic-encephalopathy.htm
    var cm_role = "live" var cm_host = "tripod.lycos.com" var cm_taxid = "/memberembedded"
    TOC
    GI Hepatic Encephalopathy (HE) SX DX RX Hepatic encephalopathy is a complex neuropsychiatric disorder that complicates acute and chronic liver failure. HE is a potentially reversible metabolic disorder of the brain in the milieu of hepatic failure. Patients with chronic liver disease develop a more indolent encephalopathy, called portosystemic encephalopathy (PSE) SX of encephalopathy:
    DX of hepatic encephalopathy:
    Stages of overt hepatic encephalopathy:
  • Patients exhibit inappropriate behavior, altered sleep pattern, loss of affect, depression, or euphoria. There is usually asterixis and difficulty with writing and other fine motor skills.
  • Patients are moderately obtunded, confused, and disoriented. There is accompanying fetor hepaticus and asterixis.
  • Patients are stuporous with marked confusion. They are barely responsive to painful stimuli. If it can be elicited, asterixis should be present. There is usually hyperreflexia, clonus, rigidity of limbs, extensor response, grasping, and sucking responses.
  • Patients are in deep coma, usually with no response to stimuli. Muscle tone may be totally absent, limbs flaccid, and reflexes depressed.
  • 85. :: Ez2Find :: Hepatic Encephalopathy
    Guide hepatic encephalopathy, Global Metasearch Any Language Guides, HepaticEncephalopathy. ez2Find Home Directory Health Conditions
    http://ez2find.com/cgi-bin/directory/meta/search.pl/Health/Conditions_and_Diseas
    Guide : Hepatic Encephalopathy Global Metasearch
    Any Language English Afrikaans Arabic Bahasa Melayu Belarusian Bulgarian Catala Chinese Simplified Chinese Traditional Cymraeg Czech Dansk Deutsch Eesti Espanol Euskara Faroese Francais Frysk Galego Greek Hebrew Hrvatski Indonesia Islenska Italiano Japanese Korean Latvian Lietuviu Lingua Latina Magyar Netherlands Norsk Polska Portugues Romana Russian Shqip Slovensko Slovensky Srpski Suomi Svenska Thai Turkce Ukrainian Vietnamese Mode
    All Words Any Word Phrase Results
    Timeout
    Depth
    Adult Filter Add to Favorites Other Search Web News Newsgroups Images
    Guides Hepatic Encephalopathy
    ez2Find Home Directory Health Conditions and Diseases ... Metabolic : Hepatic Encephalopathy Related Categories Health: Conditions and Diseases: Digestive Disorders: Liver
    Web Sites

    86. Specialty Laboratories ::: We Help Doctors Help Patients
    Print View. hepatic encephalopathy Tatyana Yashina, MD*, Ph.D. hepatic encephalopathy(HE) occurs in patients with acute or chronic liver diseases and
    http://www.specialtylabs.com/books/display.asp?id=200

    87. Study Of Prevalence Of H. Pylori In Hepatic Encephalopathy Due To Various Liver
    Study of prevalence of H. pylori in hepatic encephalopathy due to variousliver diseases. Journal, Indian Academy of Clinical Medicine.
    http://medind.nic.in/imvw/imvw3056.html
    Extracted from IndMED Shrimali L; Chadda VS; Singh VB; Soni PK; Nayak KC; Gupta BK. Department of Medicine, S P Medical College, Bikaner (Rajasthan) Study of prevalence of H. pylori in hepatic encephalopathy due to various liver diseases Journal, Indian Academy of Clinical Medicine. 2001 Jul-Sep; 2(3): 195-7 KEYWORDS: Liver Diseases/DI; Drug Evaluation; Serology; Prevalence; Hepatic Encephalopathy/DI; Pylorus/AH; Enzyme Link Immunosorbent Assay/MT; Seropositivity; Alcoholism/DI; Human; Male; Female; Adult References: 12 Record Identifier: NI206583

    88. Alanine Aminotransferase
    See Also Aspartate Aminotransferase. Normal Level 35 U/L. Increased Liver disease;hepatic congestion; Shock liver; Epstein Barr Virus (EBV); Myocardial Infarction;
    http://www.fpnotebook.com/GI121.htm
    Home About Links Index ... Editor's Choice document.write(code); Advertisement Gastroenterology Laboratory Cirrhosis ... Gastrin Level Assorted Pages ACE Level Alpha-fetoprotein 24 hour Urine 5-hydroxyindoleacetic acid Liver Function Test ... Parasite Examination of the Stool Alanine Aminotransferase Glutamic Pyruvate Transaminase ALT Aminotransferase Serum ALT SGPT Book Home Page Cardiovascular Medicine Dentistry Dermatology Emergency Medicine Endocrinology Gastroenterology General Medicine Geriatric Medicine Gynecology Hematology and Oncology HIV Infectious Disease Jokes Laboratory Neonatology Nephrology Neurology Obstetrics Ophthalmology Orthopedics Otolaryngology Pediatrics Pharmacology Prevention Psychiatry Pulmonology Radiology Rheumatology Sports Medicine Surgery Urology Chapter Gastroenterology Index Bowel Cirrhosis Constipation Dermatology Diarrhea Esophagus Examination Gynecology Hematology and Oncology Hepatitis Inflammatory Bowel Disease Infectious Disease Laboratory General Malabsorption Neurology Neonatology Obstetrics Pancreas Pediatrics Pharmacology Prevention Procedure Psychiatry Peptic Ulcer Disease Radiology Rectum Rheumatology Spleen Stomach Surgery Symptom Evaluation Page Laboratory Index ACE level AFP Cirrhosis Ammonia Serum Cirrhosis Antibody Anti-Mitochondrial Cirrhosis Antibody Smooth Muscle Hemeonc CEA Hemonc 5-HT Hepatitis Viral Hepatitis Viral Type A Serology Hepatitis Viral Type B Serology Hepatitis Viral Type C Serology ID Clostridium LFT LFT Abnormality Approach LFT Albumin Serum LFT Alk Phos Serum LFT ALT LFT AST LFT Bili LFT Bili Direct

    89. Hepatitis C: The Forum: Nutrition - Nutrition For Encephalopathy
    Nutrition for encephalopathy. encephalopathy More seriously, if left untreated,encephalopathy can lead to coma and death. encephalopathy
    http://www.epidemic.org/theForum/resources/nutrition/encephalopathy.html
    Section 4 of 7 Nutrition for Encephalopathy
    Encephalopathy is a condition where the brain becomes affected by the waste products and nutrients normally neutralized and balanced by the liver. It is marked by symptoms such as mental confusion, personality changes, and twitching. More seriously, if left untreated, encephalopathy can lead to coma and death. Encephalopathy is still not completely understood, but there are two major nutritional components suspected of precipitating this condition. One is a waste product from protein in the diet called ammonia . High levels of ammonia build up because the diseased liver normally helps to excrete it out of the body. Your physician will usually prescribe both a protein restriction in your diet (usually 30-50 grams of protein per day) and a medication such as lactulose which helps rid the body of ammonia. Protein should not be eliminated completely from the diet because it is still essential for the bodies nutritional needs. Another component of encephalopathy is a derangement of actual protein parts called amino acids. Amino acids are like links in a chain, the chain being the whole protein. Two major types of amino acids become both abnormally high and abnormally low in the blood during encephalopathy.

    90. Hepatic
    hepatic relating to the liver.
    http://www.hepcchallenge.org/manual/glossary/Hepatic.htm
    Hepatic -relating to the liver

    91. Synbiotic Modulation Of Gut Flora Improves Minimal Hepatic Encephalopathy In Cir
    Synbiotic modulation of gut flora improves minimal hepaticencephalopathy in cirrhotic patients. 14 May 2004
    http://www.medicalnewstoday.com/index.php?newsid=8294

    92. DrugInfoZone - Non-absorbable Disaccharides For Hepatic Encephalopathy: Systemat
    News Updates. Record Details. Title, Nonabsorbable disaccharides for hepaticencephalopathy systematic review of randomised trials. Date Published, 30/04/2004.
    http://www.druginfozone.org/record viewing/viewRecord.aspx?id=532386

    93. Benzodiazepine Receptor Antagonists For Acute And Chronic Hepatic Encephalopathy
    All rights reserved. Benzodiazepine receptor antagonists for acute and chronic hepaticencephalopathy (Cochrane Review). AlsNielsen B, Kjaergard LL, Gluud C.
    http://www.mediscope.ch/cochrane-abstracts/ab002798.htm
    From The Cochrane Libary, Issue 4, 2001 . Prepared and published by Update Software Ltd
    Benzodiazepine receptor antagonists for acute and chronic hepatic encephalopathy (Cochrane Review)
    Als-Nielsen B, Kjaergard LL, Gluud C ABSTRACT A substantive amendment to this systematic review was last made on 10 July 2001. Cochrane reviews are regularly checked and updated if necessary. Background: The pathogenesis of hepatic encephalopathy is unknown. It has been suggested that liver failure leads to the accumulation of substances that bind to a receptor-complex in the brain resulting in neural inhibition which may progress to coma. Several trials have assessed benzodiazepine receptor antagonists for hepatic encephalopathy, but the results are conflicting. Objectives: To evaluate the efficacy and safety of benzodiazepine receptor antagonists for patients with acute or chronic hepatic encephalopathy. Search strategy: Eligible trials were identified through The Cochrane Hepato-Biliary Group Controlled Trials Register, The Cochrane Controlled Trials Register, MEDLINE, EMBASE, reference lists of relevant articles, authors of trials, and the pharmaceutical company known to produce benzodiazepine receptor antagonists. Selection criteria: Randomised trials comparing any benzodiazepine receptor antagonist versus placebo or no intervention for hepatic encephalopathy were included, regardless of language or publication status.

    A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z  

    Page 5     81-93 of 93    Back | 1  | 2  | 3  | 4  | 5 

    free hit counter